CardioGard Medical
Emboli Protection System
Health Tech & Life Sciences
Non Active, Feb 2019 ceased to operate
Company Overview
Snapshot
Founded in January 2010, CardioGard Medical operated with 1–10 employees, developing an emboli protection system. The company ceased operations in February 2019.
Business overview
CardioGard Medical developed a specialized system designed to remove gaseous and solid embolic material during heart bypass surgeries. Its core technology involves a double-lumen cannula that provides oxygenated blood while simultaneously suctioning embolic matter back to a cardiopulmonary bypass machine for filtration. The single-use device integrates with existing hospital equipment, serving the healthcare and medical devices sectors, specifically targeting hospitals and cardiology applications.
Company Intelligence Q&A
- What is CardioGard Medical's primary product?
- CardioGard Medical developed an emboli protection system designed to remove gaseous and solid embolic material during heart bypass surgeries.
- When was CardioGard Medical founded?
- CardioGard Medical was founded in January 2010.
- What is the operational status of CardioGard Medical?
- CardioGard Medical ceased to operate in February 2019.
- What type of medical device did CardioGard Medical develop?
- CardioGard Medical developed a double-lumen cannula system for use in heart bypass surgeries, which provides oxygenated blood and suctions embolic material.
- Which sector did CardioGard Medical operate in?
- CardioGard Medical operated within the Health Tech & Life Sciences sector, focusing on medical devices for cardiology and surgical applications.